Dechra Veterinary Products has launched Pre-Vetoryl Cortisol (PVC) monitoring, an alternative method of monitoring dogs that are being treated for Cushing’s syndrome.

The company says the new method, which was developed with Professor Ian Ramsey at the University of Glasgow, has been introduced following recent studies that showed a lack of correlation between ACTH stimulation test results and the clinical status of dogs treated with Vetoryl ^1,2

Craig Sankey, Brand Manager at Dechra Veterinary Products, said: "Vetoryl is a medicine that will normally deliver major clinical benefits to a patient with canine Cushing's syndrome but finding a stable, long-term dosing regimen can be hard if ACTH stimulation tests return varying results.

"Pre-Vetoryl Cortisol monitoring is a reliable alternative to traditional ACTH stimulation tests for several reasons. It predicts clinical signs better, gives more consistent results, is less expensive and is easier to perform.

"Our online guide gives veterinary professionals a detailed insight into how they can integrate PVC into their treatment plans and the benefits it can bring to their patients and practice."

Information about Pre-Vetoryl Cortisol monitoring is now available at www.dechra.co.uk/prevetorylcortisol, together with other resources for patients on Vetoryl.

Dechra also hosts a website for owners whose pets have been prescribed Vetoryl: www.canine-cushings.co.uk.

References

1. WEHNER A. GLOECKNER S., SAUTER C., KRUSE D., STOCKHAUS C. & HARTMANN, K. (2013) Association between ACTH stimulation tests, clinical signs, and laboratory parameters in dogs with hyperadrenocorticism treated with Vetoryl. (Abstract) European College of Veterinary Internal Medicine Congress, Liverpool
2. MACFARLANE l., PARKIN T., RAMSEY I. (2016) Pre-trilostane and three-hour post trilostane cortisol to monitor trilostane therapy in dogs Veterinary Record 179 (23): 597

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.